Prima is intended for individuals whose central vision loss has previously restricted their ability to read or recognise ...

The Prima photovoltaic retinal stimulation microchip, a brain-computer interface device designed to restore vision in ...

Science Corporation, the neural engineering and brain-computer interface (BCI) company, today announced the European ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A tiny photovoltaic chip slipped beneath the retina gave most patients with advanced dry macular degeneration something they had lost: the ability to read letters, numbers, and words on their own. In ...

1 Faculty of Life Sciences and Medicine, King’s College London, London, UK 2 King’s Ophthalmology Research Unit (KORU), King’s College Hospital, London SE5 9RS, UK 3 Department of Population Health ...

X-linked retinoschisis is a recessive disease characterized by progressive macular degeneration and vision loss due to pathogenic variation in RS1. We administered a single subretinal injection of an ...

Investigators analyzed a large real-world dataset of more than 800,000 individual letter readings to determine if small shifts in visual acuity and contrast sensitivity constitute clinically ...

Assessment of visual function by testing for visual acuity, dark adaptation, contrast sensitivity and evaluation of retinal sensitivity by microperimetry can indicate different stages of disease ...

Despite intravitreal anti–vascular endothelial growth factor (VEGF) therapy being the standard of care for neovascular age-related macular degeneration (nAMD), long-term visual decline remains common, ...

Sheila Irvine, one of the patients who received the implant at Moorfields hospital in the UK. A wireless retinal implant has been shown to restore vision in patients with geographic atrophy (GA), a ...

The Prima implant shown next to a household key to demonstrate its size. [Image courtesy of Science Corp.] Science Corp. today announced clinical trial data demonstrating the efficacy of its Prima ...